IL50932A - Carbo(hetero)bicyclic ethanolamine derivatives,process for their preparation and pharmaceutical compositions containing them - Google Patents
Carbo(hetero)bicyclic ethanolamine derivatives,process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL50932A IL50932A IL50932A IL5093276A IL50932A IL 50932 A IL50932 A IL 50932A IL 50932 A IL50932 A IL 50932A IL 5093276 A IL5093276 A IL 5093276A IL 50932 A IL50932 A IL 50932A
- Authority
- IL
- Israel
- Prior art keywords
- carbo
- bicyclic
- hetero
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7535217A FR2332010A1 (fr) | 1975-11-18 | 1975-11-18 | Amino-alcool heterocyclique, son sel et son procede de preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL50932A0 IL50932A0 (en) | 1977-01-31 |
| IL50932A true IL50932A (en) | 1984-01-31 |
Family
ID=9162563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL50932A IL50932A (en) | 1975-11-18 | 1976-11-17 | Carbo(hetero)bicyclic ethanolamine derivatives,process for their preparation and pharmaceutical compositions containing them |
Country Status (21)
| Country | Link |
|---|---|
| JP (2) | JPS5297952A (fr) |
| AT (1) | AT355566B (fr) |
| AU (1) | AU510315B2 (fr) |
| BE (1) | BE848496A (fr) |
| CA (1) | CA1094088A (fr) |
| CH (2) | CH623321A5 (fr) |
| DE (1) | DE2651572C2 (fr) |
| DK (1) | DK151330C (fr) |
| ES (1) | ES453389A1 (fr) |
| FI (1) | FI763265A (fr) |
| FR (1) | FR2332010A1 (fr) |
| GB (1) | GB1565080A (fr) |
| GR (1) | GR62012B (fr) |
| IE (1) | IE44265B1 (fr) |
| IL (1) | IL50932A (fr) |
| MX (1) | MX4881E (fr) |
| NL (1) | NL180936C (fr) |
| NZ (1) | NZ182665A (fr) |
| PT (1) | PT65853B (fr) |
| SE (1) | SE434744B (fr) |
| ZA (1) | ZA766907B (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2512817A1 (fr) * | 1981-09-17 | 1983-03-18 | Roussel Uclaf | Nouveaux derives de l'aminomethyl 1h-indole-4-methanol et leurs sels, leur procede de preparation, leur application a titre de medicaments, les compositions les renfermant et leurs intermediaires de preparation |
| US4521606A (en) * | 1983-06-30 | 1985-06-04 | American Home Products Corp. | 5-Indolyl substituted aminoethanols |
| US4622399A (en) * | 1983-06-30 | 1986-11-11 | American Home Products Corporation | Bicyclo-heterocyclic nitrogen substituted aminoethanol derivatives |
| US4562200A (en) * | 1983-06-30 | 1985-12-31 | American Home Products Corporation | 5(Indolyl) and 5(2,3-dihydroindolyl) substituted aminoethanols and their use as anti-hypertensives |
| EP0567090B1 (fr) | 1992-04-24 | 2000-07-26 | Takeda Chemical Industries, Ltd. | Dérivés de la benzoxazépine comme inhibiteurs de la cholinésterase |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5705515A (en) * | 1994-04-26 | 1998-01-06 | Merck & Co., Inc. | Substituted sulfonamides as selective β-3 agonists for the treatment of diabetes and obesity |
| US5541197A (en) * | 1994-04-26 | 1996-07-30 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| US5656661A (en) * | 1994-07-27 | 1997-08-12 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| US5684002A (en) * | 1994-09-07 | 1997-11-04 | The Procter & Gamble Company | Dihydorbenzofuran and related compounds useful as anti-inflammatory agents |
| ATE251608T1 (de) | 1996-01-10 | 2003-10-15 | Asahi Chemical Ind | Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten |
| US5672620A (en) * | 1996-02-01 | 1997-09-30 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| US5684031A (en) * | 1996-02-01 | 1997-11-04 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| FR2758820B1 (fr) * | 1997-01-30 | 1999-02-26 | Synthelabo | Derives de alpha-azacyclomethyl-benzofurane, leur preparation et leur application en therapeutique |
| WO1998033793A1 (fr) * | 1997-01-30 | 1998-08-06 | Sanofi-Synthelabo | DERIVES DE α-AZACYCLOMETHYL BENZOTHIOPHENE ET DE α-AZACYCLOMETHYL BENZOFURANE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| CA2296104A1 (fr) * | 1997-07-03 | 1999-01-14 | Asahi Kasei Kogyo Kabushiki Kaisha | Nouveaux composes tricycliques presentant des noyaux satures et compositions medicinales les contenant |
| DK1277736T3 (da) | 2000-04-28 | 2007-10-01 | Asahi Kasei Pharma Corp | Hidtil ukendte bicykliske forbindelser |
| WO2003035620A1 (fr) | 2001-10-25 | 2003-05-01 | Asahi Kasei Pharma Corporation | Compose bicyclique |
| KR20110050733A (ko) | 2008-10-09 | 2011-05-16 | 아사히 가세이 파마 가부시키가이샤 | 인다졸 유도체 |
| EP2345644A4 (fr) | 2008-10-09 | 2012-03-21 | Asahi Kasei Pharma Corp | Composé d indazole |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1013224A (en) * | 1962-06-21 | 1965-12-15 | Ici Ltd | Heterocyclic aminoethanols |
| US3255249A (en) * | 1963-04-26 | 1966-06-07 | Ici Ltd | 2-branched lower alkyl-amino-1-(indan-, hydrogenated indan- and hydrogenated naphth-2-yl) lower alkanols |
| CH442302A (de) * | 1964-04-17 | 1967-08-31 | Sandoz Ag | Verfahren zur Herstellung eines neuen Indolderivates |
| FR2138488A1 (en) * | 1971-05-27 | 1973-01-05 | Lipha | 1-(5-indanyl)-omega-aminoalkanes - with tranquillizing activity |
-
1975
- 1975-11-18 FR FR7535217A patent/FR2332010A1/fr active Granted
-
1976
- 1976-11-11 SE SE7612554A patent/SE434744B/xx not_active IP Right Cessation
- 1976-11-12 DE DE2651572A patent/DE2651572C2/de not_active Expired
- 1976-11-15 FI FI763265A patent/FI763265A/fi not_active Application Discontinuation
- 1976-11-17 AT AT854376A patent/AT355566B/de not_active IP Right Cessation
- 1976-11-17 IL IL50932A patent/IL50932A/xx unknown
- 1976-11-17 DK DK517076A patent/DK151330C/da not_active IP Right Cessation
- 1976-11-17 ES ES453389A patent/ES453389A1/es not_active Expired
- 1976-11-17 NL NLAANVRAGE7612794,A patent/NL180936C/xx not_active IP Right Cessation
- 1976-11-17 PT PT65853A patent/PT65853B/fr unknown
- 1976-11-17 MX MX765135U patent/MX4881E/es unknown
- 1976-11-18 IE IE2541/76A patent/IE44265B1/en unknown
- 1976-11-18 CA CA266,041A patent/CA1094088A/fr not_active Expired
- 1976-11-18 BE BE172486A patent/BE848496A/fr not_active IP Right Cessation
- 1976-11-18 GR GR52209A patent/GR62012B/el unknown
- 1976-11-18 CH CH1454276A patent/CH623321A5/fr not_active IP Right Cessation
- 1976-11-18 JP JP13785976A patent/JPS5297952A/ja active Granted
- 1976-11-18 GB GB48127/76A patent/GB1565080A/en not_active Expired
- 1976-11-18 AU AU19779/76A patent/AU510315B2/en not_active Expired
- 1976-11-18 NZ NZ182665A patent/NZ182665A/xx unknown
- 1976-11-18 ZA ZA766907A patent/ZA766907B/xx unknown
-
1980
- 1980-03-03 CH CH167280A patent/CH622770A5/fr not_active IP Right Cessation
-
1982
- 1982-01-12 JP JP57002388A patent/JPS6017778B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6017778B2 (ja) | 1985-05-07 |
| MX4881E (es) | 1982-11-30 |
| SE7612554L (sv) | 1977-05-19 |
| DE2651572A1 (de) | 1977-06-08 |
| FI763265A (fr) | 1977-05-19 |
| ZA766907B (en) | 1977-10-26 |
| IE44265L (en) | 1977-05-18 |
| DK151330C (da) | 1988-04-25 |
| IL50932A0 (en) | 1977-01-31 |
| DE2651572C2 (de) | 1982-05-19 |
| GB1565080A (en) | 1980-04-16 |
| DK151330B (da) | 1987-11-23 |
| DK517076A (da) | 1977-05-19 |
| BE848496A (fr) | 1977-05-18 |
| ATA854376A (de) | 1979-08-15 |
| NL7612794A (nl) | 1977-05-23 |
| ES453389A1 (es) | 1977-11-16 |
| GR62012B (en) | 1979-02-15 |
| PT65853A (fr) | 1976-12-01 |
| IE44265B1 (en) | 1981-09-23 |
| CH622770A5 (en) | 1981-04-30 |
| JPS63435B2 (fr) | 1988-01-07 |
| FR2332010A1 (fr) | 1977-06-17 |
| AT355566B (de) | 1980-03-10 |
| JPS57145843A (en) | 1982-09-09 |
| NL180936B (nl) | 1986-12-16 |
| AU1977976A (en) | 1978-05-25 |
| NZ182665A (en) | 1978-11-13 |
| AU510315B2 (en) | 1980-06-19 |
| FR2332010B1 (fr) | 1979-06-29 |
| PT65853B (fr) | 1978-05-15 |
| NL180936C (nl) | 1987-05-18 |
| CH623321A5 (en) | 1981-05-29 |
| CA1094088A (fr) | 1981-01-20 |
| JPS5297952A (en) | 1977-08-17 |
| SE434744B (sv) | 1984-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL50932A (en) | Carbo(hetero)bicyclic ethanolamine derivatives,process for their preparation and pharmaceutical compositions containing them | |
| GB1518444A (en) | N-phenyl-imidazolidine derivatives processes for preparing them and pharmaceutical compositions containing them | |
| DE2860900D1 (en) | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HU179401B (en) | Process for preparing tetracuclic benzo-pyrazino/imidazo,diazepino/-pyrido-azepine derivatives further pharmaceutical compositions containing thereof | |
| DE3065949D1 (en) | Naphthyridine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| IL56115A (en) | 14-deoxy-14-glycoside-mutilin derivatives,process for their preparation and pharmaceutical and veterinary compositions containing them | |
| IL49911A (en) | 5-benzoyl-pyrrole-2-acetic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| DE2861317D1 (en) | Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| IL49411A0 (en) | Phenylalkane-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL51040A (en) | 2-heteroarylmethylthioethylamino-5-heteroarylalkylpyrimidin-4-one derivatives,process for their preparation und pharmaceutical compositions containing them | |
| IL49406A0 (en) | Novel imidazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL50869A (en) | Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
| DE2861361D1 (en) | 1-n-acylated-4-o-glycosyl-6-o-glycosyl-1,3-diaminocyclitol derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL50736A0 (en) | Phenoxyalkylcarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL50507A0 (en) | Phenoxyalkylcarboxylic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| IL50335A (en) | Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them | |
| GB1552460A (en) | Diphenylacetamide derivatives processes for their preparation and pharmaceutical compositions containing them | |
| DE2861767D1 (en) | Cephalosprin derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL48791A0 (en) | Novel penicillin derivatives,their preparation and pharmaceutical compositions containing them | |
| JPS5217434A (en) | Novel compound*process for preparation thereof and pharmaceutical composition | |
| GB1522212A (en) | Glutamine derivatives process for their preparation and pharmaceutical compositions containing them | |
| ZA772026B (en) | Naphthyl derivatives,processes for their preparation and pharmaceutical compositions containing them | |
| IL50399A (en) | Substituted sulphoximides,a process for their preparation and pharmaceutical compositions containing these compounds | |
| IL49864A0 (en) | New pentacyclic compounds,their preparation and pharmaceutical compositions containing them | |
| DE2962303D1 (en) | Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them |